BioSpace News Archive

Genetown

X4 Pharmaceuticals to Present Clinical Data from Pilot Study of Combination of X4P-001-IO and Opdivo® (nivolumab)

Study designed to evaluate X4P-001-IO in expanded range of combination treatment settings to be presented at the Annual Meeting of the Association for Cancer Immunotherapy

May 8, 2018

·

2 min read

Policy

US FDA Procures DILIsym Software License Package

DILIsym Services, Inc.,(NASDAQ: SLP) today announced that the U.S. Food and Drug Administration has secured an annual government license for its flagship QSP (quantitative systems pharmacology) modeling software

May 8, 2018

·

4 min read

Business

Ascendia Pharmaceuticals Announces Product Development Collaboration with KC Pharmaceuticals

For OTC Ophthalmic Drop Products

May 8, 2018

·

1 min read

Business

Zynex Announces 2018 First Quarter Earnings

- Revenue grew 100% year over year to $6.9 million - Net income of $1.9 million increased 444% year over year; Diluted EPS $0.06 - Adjusted EBITDA of $2.0 million increased 257% year over year - Seventh consecutive quarter of positive net income, 82% gross margin and 28% operating margin

May 8, 2018

·

16 min read

Drug Development

Click Therapeutics Awarded National Institutes of Health (NIH) Grant for Clickotine® Digital Therapeutic Study

Click Therapeutics, Inc., has been awarded a National Institutes of Health (NIH) Small Business Innovation and Research (SBIR) grant through the National Institute of Drug Abuse (NIDA)

May 8, 2018

·

2 min read

Genetown

RXi Pharmaceuticals Bolsters Strength of Dermatology Intellectual Property Estate Following Granting of Patent From USPTO

This patent includes RXI-109 and its use in dermal scarring, for which the safety and efficacy was shown in a recent Phase 2 clinical trial with statistically significant outcomes for improved visual appearance for RXI-109 treated scar over control.

May 8, 2018

·

4 min read

Business

TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2018

During the first quarter ended March 31, 2018, the Company sold two Senhance Systems.

May 8, 2018

·

13 min read

Deals

Univar Announces Agreement to Acquire Earthoil

The acquisition is expected to close at the end of May 2018.

May 8, 2018

·

4 min read

Business

Bio-Rad Reports First Quarter 2018 Financial Results

First-quarter 2018 net sales were $551.5 million, an increase of 10.3 percent compared to $500.1 million reported for the first quarter of 2017

May 8, 2018

·

21 min read

Business

Motif Bio to Present Iclaprim Data at ASM Microbe 2018

Motif Bio plc announced that two iclaprim abstracts have been accepted for presentation at the upcoming American Society For Microbiology (ASM) Microbe 2018 meeting to be held in Atlanta, GA, USA, June 7-11, 2018.

May 8, 2018

·

5 min read